Propionic Acid

Propionic Acid

SCHEMBL28643153

CCC(=O)O.Cc1ccccc1NCc1ccccc1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2C P18825 1/20 0.58
HDAC8 Q9BY41 3/20 0.55
HDAC1 Q13547 1/20 0.55
HDAC6 Q9UBN7 1/20 0.55
HPGD P15428 3/20 0.53
HSD17B10 Q99714 2/20 0.51
KMT2A Q03164 4/20 0.50
MEN1 O00255 3/20 0.50
HTT P42858 3/20 0.50
KDM4E B2RXH2 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
SCD O00767 2/20 0.49
MAPT P10636 3/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
CRHBP P24387 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL29049218 0.89 HSD17B10 (0.54) ADRA2CHDAC8HDAC1HDAC6HSD17B10
SCHEMBL3440796 0.88 ADRA2C (0.72) ADRA2CHDAC8HDAC1HDAC6HPGD
Bromide SCHEMBL30496129 0.86 ADRA2C (0.70) ADRA2CHDAC8HDAC1HDAC6HPGD
Malonic Acid SCHEMBL29049213 0.81 HSD17B10 (0.55) ADRA2CHDAC8HDAC1HDAC6HPGD
Bicarbonate SCHEMBL29049243 0.80 HSD17B10 (0.58) ADRA2CHDAC8HDAC1HDAC6HPGD
Butyric Acid SCHEMBL29049202 0.79 POLB (0.53) HDAC8HDAC1HDAC6HSD17B10KMT2A
N-Benzylaniline SCHEMBL11480512 0.79 FFAR1 (0.64) HDAC8HDAC1HDAC6KMT2AMEN1
Acetic Acid SCHEMBL29049224 0.79 HSD17B10 (0.56) ADRA2CHDAC8HDAC1HDAC6HPGD
SCHEMBL8009873 0.79 KDM4E (0.54) ADRA2CHDAC8HDAC1HDAC6HPGD
Oxalic Acid SCHEMBL29049203 0.79 HSD17B10 (0.56) ADRA2CHDAC8HDAC1HDAC6HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108026028-B Treatment of diabetes and metabolic syndrome with novel dual modulators of soluble epoxide hydrolase and peroxisome proliferator-activated receptors 威斯康星州医药大学股份有限公司 2021-11-09 CN disclosed